SCHEMBL14009189

SCHEMBL14009189

O=C(Nc1ccc(-n2cncn2)cc1)c1ccc(C(=O)NC2CCNCC2)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMYD3 Q9H7B4 1/20 0.47
▸ ROCK1 Q13464 1/20 0.41
▸ S1PR1 P21453 1/20 0.41
▸ MAPKAPK2 P49137 1/20 0.40
▸ SYK P43405 1/20 0.39
▸ PDE7A Q13946 2/20 0.38
▸ EPHX1 P07099 1/20 0.38
▸ HDAC3 O15379 1/20 0.38
▸ HDAC4 P56524 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC7 Q8WUI4 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC11 Q96DB2 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ HDAC9 Q9UKV0 1/20 0.38
▸ HDAC5 Q9UQL6 1/20 0.38
▸ KCNH2 Q12809 2/20 0.38
▸ SCN5A Q14524 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14009200 0.94 SMYD3 (0.43) SMYD3ROCK1S1PR1MAPKAPK2SYK
SCHEMBL14009108 0.93 SMYD3 (0.53) SMYD3ROCK1S1PR1SYKHSP90AA1
SCHEMBL14009091 0.91 SMYD3 (0.49) SMYD3ROCK1S1PR1SYKALDH1A1
SCHEMBL14009095 0.91 SMYD3 (0.49) SMYD3ROCK1S1PR1SYKALDH1A1
SCHEMBL14009119 0.90 SMYD3 (0.48) SMYD3ROCK1S1PR1SYKEPHX1
SCHEMBL14009180 0.87 SMYD3 (0.46) SMYD3ROCK1S1PR1SYKPDE7A
SCHEMBL14009112 0.86 SMYD3 (0.46) SMYD3ROCK1S1PR1SYKPDE7A
SCHEMBL14009164 0.84 SMYD3 (0.45) SMYD3ROCK1S1PR1SYKHSP90AA1
SCHEMBL14009174 0.82 NAMPT (0.47) SMYD3ROCK1S1PR1MAPKAPK2HDAC3
SCHEMBL14009038 0.81 S1PR1 (0.41) SMYD3ROCK1S1PR1SYKPDE7A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-7446195-B2 High affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION (US) 2008-11-04 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands SCHERING CORPORATION 2007-02-22 — — US disclosed
WO-2007022258-A1 NOVEL HIGH AFFINITY THIOPHENE-BASED AND FURAN-BASED KINASE LIGANDS SCHERING CORPORATION (US) 2007-02-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043045-A1 Novel high affinity thiophene-based and furan-based kinase ligands CDKL2, CDK2, CDKL1 SMYD3 3202/4885ROCK1 1401/4885S1PR1 2163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback